Surgical management of oligometastatic recurrence in primary esophageal melanoma: a feasible approach in resource-limited settings
Primary esophageal melanoma (PEM) is a rare and aggressive malignancy with limited treatment options. Due to its rarity, no standardized guidelines exist for managing oligometastatic recurrence, particularly in resource-limited settings. We present a case of a 60-year-old male with PEM who underwent esophagectomy followed by surgical resection of an adrenal metastasis. Despite the increasing use of immunotherapy, surgical resection remains a viable alternative for oligometastatic recurrence when access to systemic therapies is restricted. This case highlights the feasibility of surgery in achieving long-term disease control in select patients. Further studies are needed to establish evidence-based strategies for treating PEM recurrence in resource-constrained environments.
Authors
- Yurii Kondratskyi (ORCID: https://orcid.org/0000-0003-3664-5903)
- Oleksii Dobrzhanskyi (ORCID: https://orcid.org/0000-0001-9422-4977)
- A. V. Kolesnyk
- Mykhailo Krotevych (ORCID: https://orcid.org/0000-0002-5228-7491)
- Y. Shudrak (ORCID: https://orcid.org/0009-0003-6270-2518)
- Andrii Horodetskyi
- Mykyta Pepenin (ORCID: https://orcid.org/0009-0008-1803-1979)
Institutions
- National Cancer Institute (UA)
Publication Details
- Journal
- Journal of Surgical Case Reports
- Published
- 2025-03-01
- DOI
- https://doi.org/10.1093/jscr/rjaf123
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00